U.S. patent number RE38,385 [Application Number 09/939,688] was granted by the patent office on 2004-01-13 for storage of materials.
This patent grant is currently assigned to Nektar Therapeutics. Invention is credited to Felix Franks, Ross H. M. Hatley.
United States Patent |
RE38,385 |
Franks , et al. |
January 13, 2004 |
Storage of materials
Abstract
A material or mixture of materials which is not itself storage
stable is rendered storage stable by incorporation into a
water-soluble or swellable glassy or rubbery composition which can
then be stored at ambient temperature. Recovery is by adding
aqueous solution to the composition.
Inventors: |
Franks; Felix (Cambridge,
GB), Hatley; Ross H. M. (Cambridge, GB) |
Assignee: |
Nektar Therapeutics (San
Carlos, CA)
|
Family
ID: |
27264327 |
Appl.
No.: |
09/939,688 |
Filed: |
August 28, 2001 |
Related U.S. Patent Documents
|
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
Issue Date |
|
|
270791 |
Mar 17, 1999 |
Re37872 |
|
|
Reissue of: |
479939 |
Feb 12, 1990 |
05098893 |
Mar 24, 1992 |
|
|
Foreign Application Priority Data
|
|
|
|
|
Feb 16, 1989 [GB] |
|
|
8903593 |
|
Current U.S.
Class: |
514/54; 424/465;
424/486; 424/488; 424/94.3; 435/188; 514/1.1; 514/44R; 514/45;
514/48; 514/49; 514/970; 530/427 |
Current CPC
Class: |
A61K
9/145 (20130101); A61K 9/146 (20130101); A61K
47/26 (20130101); A61K 47/36 (20130101); C12N
9/96 (20130101); C12N 11/08 (20130101); C12N
11/10 (20130101) |
Current International
Class: |
A61K
9/14 (20060101); A61K 47/36 (20060101); A61K
47/26 (20060101); C12N 9/96 (20060101); C12N
11/08 (20060101); C12N 11/00 (20060101); C12N
11/10 (20060101); A61K 009/26 (); A61K 031/715 ();
A61K 038/02 (); C07K 017/00 (); C12N 011/00 () |
Field of
Search: |
;424/440,459,461,462,94.1,94.3,400,486,487,488
;514/54,948,970,971,3,4,12,21,44,45,46,47,48,49,50,51,52
;530/303,304,305,390.5,397,399,427 ;435/188 |
References Cited
[Referenced By]
U.S. Patent Documents
Foreign Patent Documents
|
|
|
|
|
|
|
159826 |
|
Mar 1972 |
|
DE |
|
0 111 216 |
|
Jun 1984 |
|
EP |
|
0140 489 |
|
May 1985 |
|
EP |
|
0229 810 |
|
Jul 1987 |
|
EP |
|
252750 |
|
Jan 1988 |
|
EP |
|
0 297 887 |
|
Jan 1989 |
|
EP |
|
223221 |
|
Mar 1989 |
|
EP |
|
244771 |
|
Mar 1989 |
|
EP |
|
0 520 748 |
|
Dec 1992 |
|
EP |
|
2 126 588 |
|
Mar 1984 |
|
GB |
|
70-12153 |
|
Jan 1970 |
|
JP |
|
55-97096 |
|
Jul 1980 |
|
JP |
|
8600336 |
|
Jan 1986 |
|
WO |
|
WO 86/04095 |
|
Jul 1986 |
|
WO |
|
8700196 |
|
Jan 1987 |
|
WO |
|
WO 87/00196 |
|
Jan 1987 |
|
WO |
|
WO 87/05300 |
|
Sep 1987 |
|
WO |
|
WO 89/06542 |
|
Jul 1989 |
|
WO |
|
WO 90/05182 |
|
May 1990 |
|
WO |
|
Other References
US. patent application Ser. No. 09/270,791, Filed Mar. 17, 1999,
Pending. .
U.S. patent application Ser. No. 09/939,689, Filed Aug. 28, 2001,
Pending. .
The Effect of Sugars on the Thermal Dentation of Lysozyme H7H
Uedaira Bull chem Soc 53 2451 (1980). .
Modes of Stabilization of a Protein by Organic Solutes during
Desiccation; John F. Carpenter and John H. Crowe, Department of
Zoology, Universtiy of California, Davis, California Crybiology 25
pp. 459-470 (1988). .
Principles of "Cryostabilization" Technology from
Structure/Property Relationships of Carbohydrate/Water systems--A
Review, Harry Levine and Louise Slade, Nabisco Brands, Inc.,
Corporate Technology Group, Cryoletters 9 pp. 21-63 (1988). .
The Glassy State and Survival of Anhydrous Biological Systems,
Michael J. Burke, pp. 358-363, (1986) in Membranes, Metabolism, and
Dry Organisms, A.C. Leopold, ed. .
Use of Lyoprotectants in the Freeze-Drying of a Model Protein,
Ribonuclease, Michael W. Townsend and Patrick P. DeLuca, Journal of
Parenteral Science & Technology, 42 pp. 190-199 (1988). .
Structure and Structure Transitions in Dried Carbohydrate
Materials, James M. Flink, Physical Properties of Foods, pp.
473-521 (1983). .
Some Physico-Chemical Properties of Lactose, B. L. Herrington, J
Dairy Science, 17, pp. 501-519, (1934). .
The Glassy State in Certain Sugar-Containing Food Products, G.W.
White and S.H. Cakebread, J Food Technol. 1 pp. 73-82 (1966). .
Loss of Structure in Freeze-dried Carbohydrates Solutions: Effect
of Temperature, Moisture Content and Composition, Spyros
Tsourouflis, James M. Flink, and Marcus Karel, J Sci Fd-Agric 27,
pp. 509-519 (1976). .
Structural Stability of Intermediate Moisture Foods--A New
Understanding, Louise Slade and H. Levine, Food Structure, its
Creation and Evaluation, Blanshard and Mitchell, pp. 115-180
(1988). .
The Nature of Glassy State and the Behavior of Liquids at Low
Temperatures, Kauzmann Chem Rev 43, pp. 219-227 (1948). .
A Polymer Physico-Chemical Approach to the Study of Commercial
Starch Hydrolysis Products (SHPs), Harry Levine and Louise Slade,
Carbohydrate Polymers, 6 pp. 213-244 (1986). .
Stabilization of Phosphofructokinase during Air-Drying with Sugars
and Sugar/Transition Metal Mixtures, John f. Carpenter, Beth
Martin, Lois M. Crowe, and John H. Crowe, Cryobiology, 24 pp.
455-464 (1987). .
Thermostability of Enzyme in the Three-dimensional Network of
Polysaccharide Chains, Z. Schneider, A. Stroinski and J.
Pawelkiewiz, Bulletin de L'Acad. Polonnaise des Sciences XV1,4 pp.
203 and 204 (1968). .
Preservation of the Enzymatic Activity of Rennin during Spray
Drying and During Storage, and the Effect of Sugars and Certain
Other Additives, M. J. van de Beek and S. Y. Gerlsma, Neth Mild
Dairy J. 23 pp. 46-5 (1969). .
The Condensed Chemical Dictionary, Seventh Edition, Arthur and
Elizabeth Rose, Reinhold Publishing Corporation, p. 448 (1961).
.
Walter Relations of Foods, R.B. Duckworth, Editor, Academic Press,
p. 648 (1975). .
The New Encyclopedia Britannica, vol. 16, Encyclopedia Britannica,
Inc., pp. 476-479 (1985). .
Hydration-induced Conformational and Flexibility Changes of
Lysozyme at Low Water Content, P.L. Poole and J.L. Finney, Int J.
Biol. Macromol., 5 pp. 308-310 (1983). .
Sequential Hydration of a Dry Globular Protein, P.L. Poole and J.L.
Finney, Biopolymers, 22 pp. 255-260 (1983). .
Protein Hydration and Enzyme Activity: The Role of
Hydration-Induced Conformation and Dynamic changes in the Activity
of Lysozyme, J.L. Finney and P.L. Poole, Comments Mol Cell Biophys,
2 pages 129-151 (1984). .
Dielectric Studies of Protein Hydration and Hydration-induced
Flexibility, Bone and Pethig, J. Mol. Biol., 181 pp. 323-326
(1985). .
Production of Trehalose Dried Eggs, Quandrant Experimental Data
(not dated). .
Lyophilization of Biotechnology Products, Arno T. P. Skrabanaja,
Andre L. J. De Meere, Rein A. De Ruiter, and Piet J.M. Van Den
Detelaar, PDA Journal, 48-6 pp. 311-317 (1994). .
Permazyme Technology, Permazyme leaflet (not dated). .
BioPharm, Roser, Biopharm, pp. 49-53, Sep. 1991. .
Developments in Biological Standardization, Pikal and Sah
International Symposium on Biological Products Freeze-Drying and
Formulation Bethesda, USA, 74 pp. 165-170 (1991). .
Ready-To-To.TM. DNA Labeling Kit, Promotional Lecture (Not dated).
.
Analects.RTM., Promotional Lecture (Not dated--1992 or later).
.
Ready-To-To.TM. Kits for a broad range of Techniques in Molecular
Biology, Designed for results--mot surprises, Promotional Lecture
(Not dated). .
Psychrometric Chart (not dated). .
Green and Angell, J. Phys. Chem, 89, 2880 (1989). .
Another View of Trehalose for Drying and Stabilizing Biological
Materials, Levine and Slade, BioPharm, 1992. .
The Crystalisation of Hydrates From Amorphous Carbohydrates, Barry
J. Aldous, Anthony D. Auffret, and Felix Franks, Cryo-Letters, 16
pp. 181-186 (1995). .
Physical Characterization of Spray Dried Sugars Suitable A Carriers
in Inhalation Systems, Venkatesh Nani, Peter R. Byron and Elaine M.
Phillips, Aerosol Research Group, Poster at Tenth annual AAPS,
Miami, FL--PT6180 (not dated). .
ROOS--Carbohydrate Research, 238, 37-48 (1993). .
"The Spray Drying of Enzyme Rennin", Vipin Dhirajlal Shah,
University Microfilms, Inc. Ann Arbor Michigan (1963). .
Opinion in Inhale v. Quadrant, Case No. HC1999 No. 04555 (Jun. 20,
2001). .
Oct. 14, 1999 letter from Mewburn Ellis to EPO. .
Sep. 20, 1999 Letter from Gill Jennings & Every to EPO. .
Declaration under 37 CFR 1.132 re: Franks et al. Ser. No.
08/241,457; filed May 11, 1994; for storage of materials dated Feb.
23, 1996. .
Supplemental Amendment re: Franks et al. Ser. No. 08/241,457; filed
May 11, 1994; for storage of materials dated Apr. 22, 1996. .
Document in No. 92 305 769.9--Communication/Minutes (Annex) dated
Jul. 17, 1998. .
Opposition by Quadrant to Inhale EP 0,383,569; Declaration by
Nicholas David Osborne (Unsigned; Sep. 1999). .
Opposition by Quadrant to Inhale EP 0,383,569; Declaration by
Trevor George Gard (Unsigned; Sep. 1999). .
Clas et al. Differential Scanning Calorimentry: Applications in
Drug Development,; Research Focus/Reviews vol. 2, No. 8, Aug. 1999,
pp. 311-320. .
Sep. 13, 1999 letter from Gill Jennings & Every to EPO. .
Green et al., "The Journal of Physical Chemistry," Phase Relations
and Vitrification in Saccharide--Water Solutions and the Trehalose
Anomaly vol. 93, No. 8, 1989 pp. 2880-2882. .
Japanese patent publication Sho 60-244288 (1985-244288) 1985
(translation). .
Labrude et al., s.t.p. pharma, Jun. 1988 No. 6; pp. 472-480. .
Labrude et al., "Journal of Pharmaceutical Sciences; vol. 78, No.
3, Mar. 1989"; pp. 223-229. .
Fax from Eric Potter Clarkson to EPO dated Oct. 15, 1999 re:
Further Submissions of Novo Nordisk (Opponent 2). .
Oct. 26, 1999 letter/fax from Mewburn Ellis to EPO containing:
letter dated Oct. 15, 1999 to EPO form Akzo Nobel. .
Nov. 29, 1999 letter from Mewburn Ellis to EPO. .
Dec. 3, 1999 letter from Eric Potter Clarkson to EPO re: Opposition
to European Patent Application No. 903101561.8 (0383569). .
"The Journal of Physical Chemistry," vol. 78, No. 28, 1974;
Dependence of the Glass Transition Temperature on Heating and
Cooling Rate, pp. 2673-2677. .
Vo. 41. No. 9, 1968; "Glass Transition in Dehydrated Amorphous
Solid", Bull. Chem. Soc. Japan, p. 2322. .
Mar. 6, 2000 letter/fax from Mewburn Ellis to EPO. .
Nov. 1, 1999 fax from Simmons & Simons, containing claim form
and draft amended pleadings. .
Hatley et al., Biotechnology & Applied Biochemistry, 11,
367-370 (1989).* .
Polinsky et al., Proc. Natl. Acad. Sci. USA, 72, No. 9, 3310-3314
(1975).* .
Slade et al., Pure and Applied Chem., 60, No. 12, 1841-1864
(1988).* .
Hatley et al., Process Biochemistry, 169-172 (Dec. 1987).* .
Pure and Applied Chemistry, vol. 60, 1841-1864, Slade and Levine,
"Non-Equilibrium Behaviour of small Carbohydrate Water
Systems"..
|
Primary Examiner: Russel; Jeffrey E.
Attorney, Agent or Firm: Cagan; Felissa H. Neifeld; Richard
A. Evans; Susan T.
Parent Case Text
.Iadd.Notice: More than one reissue application has been filed for
the reissue of U.S. Pat. No. 5,098,893. The reissue applications
are application Ser. No. 09/270,791, and application Ser. Nos.
09/939,688 and 09/939,689, which are continuation reissue
applications of application Ser. No. 09/270,791. Application Ser.
No. 09/270,791 issued as Re 37,872 on Oct. 8, 2002..Iaddend.
Claims
We claim: .[.
1. A composition which is storage stable at 20.degree. C.
comprising: i) a carrier substance which is water-soluble or
water-swellable and is in a glassy amorphous state; ii) at least
one material to be stored, which is unstable in aqueous solution at
room temperature of 20.degree. C. dissolved in said amorphous
carrier substance, said composition existing in a glassy state at
20.degree. C..]. .[.
2. A composition according to claim 1 wherein the material to be
stored is selected from proteins, peptides, nucleosides,
nucleotides, dimers or oligomers of nucleosides or nucleotides,
enzyme cofactors, and derivatives of any of the foregoing having
one or more additional moieties bound thereto..]..[.
3. A composition according to claim 1 having a water content not
exceeding 4% by weight..]..[.
4. A composition according to claim 1 wherein the composition
displays a glass transition temperature of at least 30.degree.
C..]..[.
5. A composition according to claim 1 wherein carrier substance is
selected from carbohydrates and derivatives thereof which are
polyhydroxy compounds..]..[.
6. A composition according to claim 5 wherein the carrier substance
is a sugar polymer containing sugar residues linked through ether
bridges to bifunctional groups other than carbohydrate..]..[.
7. A composition according to claim 1 wherein the carrier substance
is a synthetic polymer..]..[.
8. A composition according to claim 1 wherein said material to be
stored comprises a material which is unstable when alone in aqueous
solution at room temperature..]..[.
9. A composition according to claim 1 wherein said material to be
stored comprises a plurality of materials..]..[.
10. A composition according to claim 9 wherein said material to be
stored comprises a plurality of materials which react together in
aqueous solution..]..[.
11. A composition according to claim 1 which can be stored without
refrigeration for at least 1 week..]..[.
12. A method of rendering a material storage stable at 20.degree.
C., which material is unstable in aqueous solution at room
temperature of 20.degree. C., comprising dissolving the material in
a carrier substance which is water-soluble or water-swellable, or
in a solution thereof, so that the material is dissolved in said
carrier substance, and forming the resulting mixture into a glassy
amorphous state, said mixture existing in said glassy state at
20.degree. C..]..[.
13. A method according to claim 12 wherein forming the said mixture
into an amorphous state is effected by evaporation under
subatmospheric pressure..]..[.
14. A method according to claim 13 wherein evaporation is commenced
at a temperature of 20 to 40.degree. C. and subsequently continued
at a temperature of 40 to 70.degree. C..]..[.
15. A method according to claim 13 wherein the subatmospheric
pressure is not greater than 90% of atmospheric..]..[.
16. In a method of storing a material, which material is unstable
in aqueous solution at 20.degree. C., the improvement comprising
dissolving the material in a carrier substance which is
water-soluble or water-swellable, or in a solution thereof, so that
the material is dissolved in said carrier substance, forming the
resulting mixture into a glassy amorphous state and storing the
mixture in said glassy amorphous state without refrigeration for at
least one week..]..Iadd.
17. A method of rendering a purified biologically active material
storage-stable at 20.degree. C., which material is unstable in
aqueous solution at 20.degree. C., comprising the steps of: (1)
dissolving to form an aqueous solution of (a) a quantity of a
purified biologically active material, which material is unstable
in aqueous solution at 20.degree. C., which material is selected
from the group consisting of peptides, proteins, nucleosides,
nucleotides, dimers or oligomers of nucleosides or nucleotides,
enzymes, enzyme cofactors and derivatives of any of the foregoing,
said derivatives having one or more additional moieties bound
thereto and (b) a quantity of a carrier substance that is
water-soluble or water-swellable; (2) evaporating liquid water from
said aqueous solution, thereby forming a quantity of a composition;
and (3) determining whether said composition formed by said step of
evaporating exists in a glassy state at or above 20.degree.
C..Iaddend..Iadd.
18. A method of rendering a purified biologically active material
storage-stable at 20.degree. C., which material is unstable in
aqueous solution at 20.degree. C., comprising the steps of: (1)
dissolving to form an aqueous solution of (a) a quantity of a
purified biologically active material, which material is unstable
in aqueous solution at 20.degree. C., which material is selected
from the group consisting of peptides, proteins, nucleosides,
nucleotides, dimers or oligomers of nucleosides or nucleotides,
enzymes, enzyme cofactors and derivatives of any of the foregoing,
said derivatives having one or more additional moieties bound
thereto, and (b) a quantity of a carrier substance that is
water-soluble or water-swellable; (2) evaporating liquid water from
said aqueous solution, thereby forming a quantity of a composition;
(3) determining whether said composition formed by said step of
evaporating has a glass transition temperature at or above
20.degree. C..Iaddend..Iadd.
19. The method of any of claims 17 and 18 further comprising the
steps of: recovering said purified biologically active material
without any substantial storage; and comparing activity of the
recovered purified biologically active material to activity of said
purified biologically active material prior to
storage..Iaddend..Iadd.
20. The method of any one of claims 17 and 18 wherein said purified
biologically active material is not an enzyme..Iaddend..Iadd.
21. The method of any one of claims 17 and 18 wherein said purified
biologically active material is a peptide or protein other than an
enzyme..Iaddend..Iadd.
22. The method of any one of claims 17 and 18 wherein said purified
biologically active material is a hormone other than an
enzyme..Iaddend..Iadd.
23. The method of any one of claims 17 and 18 wherein said purified
biologically active material is a blood clotting factor other than
an enzyme..Iaddend..Iadd.
24. The method of any one of claims 17 and 18 wherein said purified
biologically active material comprises a member selected from the
group consisting of immunoglobulin, an enzyme cofactor, a
nucleoside, a nucleotide, a dinucleotide, a dimer of a nucleoside,
a dimer of a nucleotide, an oligomer of a nucleoside, and an
oligomer of a nucleotide..Iaddend..Iadd.
25. The method of any one of claims 17 and 18 wherein said purified
biologically active material comprises a
hormone..Iaddend..Iadd.
26. The method of any one of claims 17 and 18 wherein said purified
biologically active material comprises a transport
protein..Iaddend..Iadd.
27. The method of any one of claims 17 and 18 wherein said purified
biologically active material comprises a blood clotting
factor..Iaddend..Iadd.
28. The method of any one of claims 17 and 18 wherein said purified
biologically active material comprises a
peptide..Iaddend..Iadd.
29. The method of any one of claims 17 and 18 wherein said purified
biologically active material comprises an
enzyme..Iaddend..Iadd.
30. The method of any one of claims 17 and 18 wherein said purified
biologically active material comprises a pharmacologically active
protein..Iaddend..Iadd.
31. The method of any one of claims 17 and 18 wherein said purified
biologically active material comprises a
dehydrogenase..Iaddend..Iadd.
32. The method of any one of claims 17 and 18 wherein said purified
biologically active material comprises a restriction
enzyme..Iaddend..Iadd.
33. The method of any one of claims 17 and 18 wherein said purified
biologically active material comprises an oxidase
enzyme..Iaddend..Iadd.
34. The method of any one of claims 17 and 18 wherein said purified
biologically active material comprises a reductase
enzyme..Iaddend..Iadd.
35. The method of any one of claims 17 and 18 wherein said purified
biologically active material comprises a restriction
endonuclease..Iaddend..Iadd.
36. The method of any one of claims 17 and 18 wherein said purified
biologically active material comprises a member selected from the
group consisting of ascorbate oxidase, cytochrome C reductase,
Glycerol-3-phosphate reductase, alpha-glucosidase, and
LDH..Iaddend..Iadd.
37. The method of any one of claims 17 and 18 wherein said carrier
substance comprises a member selected from the group consisting of
polydextrose, inulin, stachyose, dextran, sorbose, polyacrylamide,
GPS, palatinit, and maltotriose..Iaddend..Iadd.
38. The method of any one of claims 17 and 18 wherein said carrier
substance comprises a carbohydrate..Iaddend..Iadd.
39. The method of any one of claims 17 and 18 wherein said carrier
substance comprises a sugar..Iaddend..Iadd.
40. The method of any one of claims 17 and 18 wherein said carrier
substance comprises a polysaccharide..Iaddend..Iadd.
41. The method of any one of claims 17 and 18 wherein said carrier
substance comprises a disaccharide..Iaddend..Iadd.
42. The method of any one of claims 17 and 18 wherein said step of
determining comprises determining whether said composition exists
in a glassy state at between 20.degree. C. and 150.degree.
C..Iaddend..Iadd.
43. The method of any one of claims 17 and 18 wherein said step of
determining comprises determining whether said composition exists
in a glassy state at between 25.degree. C. and 150.degree.
C..Iaddend..Iadd.
44. The method of any one of claims 17 and 18 wherein said step of
determining comprises determining whether said composition exists
in a glassy state at between 43.degree. C. and 70.degree.
C..Iaddend..Iadd.
45. The method of any one of claims 17 and 18 wherein said step of
determining comprises determining whether said composition exists
in a glassy state at between 55.degree. C. and 70.degree.
C..Iaddend..Iadd.
46. A method of rendering a purified biologically active material
storage-stable at 20.degree. C., which material is unstable in
aqueous solution at 20.degree. C., comprising the steps of: (1)
dissolving to form an aqueous solution of (a) a purified
biologically active material which is unstable in aqueous solution
at 20.degree. C. and which is selected from the group consisting of
peptides, proteins, nucleosides, nucleotides, dimers or oligomers
of nucleosides or nucleotides, enzymes, enzyme cofactors and
derivatives of any of the foregoing, said derivatives having one or
more additional moieties bound thereto and (b) a carrier substance
that is water-soluble or water-swellable; (2) evaporating liquid
water from said solution, thereby converting said solution into a
glassy state composition, wherein said glassy state composition
exists when at 20.degree. C.; wherein said evaporating is done
without heating; and wherein said carrier substance comprises a
member of the group consisting of inulin, polydextrose, stachyose,
dextran, sorbose, polyacrylamide, GPS, and
palatinit..Iaddend..Iadd.
47. A glassy state composition which is storage-stable at
20.degree. C., comprising: (1) a carrier substance which is
water-soluble or water-swellable; (2) at least one material to be
stored which is dissolved in said carrier substance; wherein said
composition including said carrier substance has the property of
being in a glassy state and being storage stable when at 20.degree.
C.; wherein said at least one material comprises a purified
biologically active material that is unstable in aqueous solution
at 20.degree. C. and is selected from the group consisting of
peptides, proteins, nucleosides, nucleotides, dimers or oligomers
of nucleosides or nucleotides, enzymes, enzyme cofactors and
derivatives of any of the foregoing, said derivatives having one or
more additional moieties bound thereto; and wherein said carrier
substance comprises a member of the group consisting of inulin,
polydextrose, stachyose, dextran, sorbose, polyacrylamide, GPS, and
palatinit..Iaddend..Iadd.
48. A method of forming a glassy state composition which is
storage-stable at 20.degree. C., comprising the steps of: (1)
dissolving to form an aqueous solution of (a) at least one material
to be stored and (b) a carrier substance which is water-soluble or
water-swellable; (2) evaporating water from said solution, thereby
forming said glassy state composition; wherein said glassy state
composition including said carrier substance has the property of
being in said glassy state and being storage stable when at
20.degree. C.; wherein said at least one material comprises a
purified biologically active material that is unstable in aqueous
solution at 20.degree. C. and is selected from the group consisting
of peptides, proteins, nucleosides, nucleotides, dimers or
oligomers of nucleoside or nucleotides, enzymes, enzyme cofactors
and derivatives of any of the foregoing, said derivatives having
one or more additional moieties bound thereto; and wherein said
carrier substance comprises a member of the group consisting of
inulin, polydextrose, stachyose, dextran, sorbose, polyacrylamide,
GPS, and palatinit..Iaddend..Iadd.
49. A glassy state composition which is storage-stable at
20.degree. C., comprising: (1) a carrier substance which is
water-soluble or water-swellable; (2) at least one material to be
stored which is dissolved in said carrier substance; wherein said
glassy state composition including said carrier substance has the
property of being in a glassy state and being storage stable when
at 20.degree. C.; wherein said glassy state composition contains no
more than 4% by weight water; and wherein said at least one
material comprises a purified biologically active material that is
unstable in aqueous solution at 20.degree. C. and is selected from
the group consisting of a hormone, immunoglobulin, a transport
protein, a blood clotting factor, an enzyme cofactor, an oxidase
enzyme, a reductase enzyme, a dehydrogenase, a restriction enzyme,
a nucleoside, a nucleotide, a dinucleotide, a dimer of a
nucleoside, an oligonucleotide, and an oligomer of a
nucleoside..Iaddend..Iadd.
50. A method of forming a composition which is storage-stable at
20.degree. C., comprising the steps of: (1) dissolving to form an
aqueous solution of (a) at least one material to be stored and (b)
a carrier substance which is water-soluble or water-swellable; (2)
evaporating water from said solution, thereby forming said glassy
state composition; wherein said glassy state composition including
said carrier substance has the property of being in a glassy state
and being storage stable when at 20.degree. C.; wherein said glassy
state composition contains no more than 4% by weight water; and
wherein said at least one material comprises a purified
biologically active material that is unstable in aqueous solution
at 20.degree. C. and is selected from the group consisting of a
hormone, immunoglobulin, a transport protein, a blood clotting
factor, an enzyme cofactor, an oxidase enzyme, a reductase enzyme,
a dehydrogenase, a restriction enzyme, a nucleoside, a nucleotide,
a dinucleotide, a dimer of a nucleoside, an oligonucleotide, and an
oligomer of a nucleoside..Iaddend..Iadd.
51. A glassy state composition which is storage-stable at
20.degree. C., comprising: (1) a carrier substance which is
water-soluble or water-swellable; (2) at least one material to be
stored which is dissolved in said carrier substance; wherein said
composition including said carrier substance has the property of
being in a glassy state and being storage stable when at 20.degree.
C.; wherein said at least one material comprises a purified
biologically active material that is unstable in aqueous solution
at 20.degree. C. and is selected from the group consisting of
peptides, proteins, nucleosides, nucleotides, dimers or oligomers
of nucleosides or nucleotides, enzymes, enzyme cofactors and
derivatives of any of the foregoing, said derivatives having one or
more additional moieties bound thereto; wherein said at least one
material comprises a second biologically active material; and
wherein the first and second biologically active materials react
with one another when in aqueous solution with one
another..Iaddend..Iadd.
52. A method of forming a glassy state composition which is
storage-stable at 20.degree. C., comprising the steps of: (1)
dissolving to from an aqueous solution of (a) at least one material
to be stored and (b) a carrier substance which is water-soluble or
water-swellable; (2) evaporating water from said solution, thereby
forming said glassy state composition; wherein said glassy state
composition including said carrier substance has the property of
being in a glassy state and being storage stable when at 20.degree.
C.; wherein said at least one material comprises a first purified
biologically active material that is unstable in aqueous solution
at 20.degree. C. and is selected from the group consisting of
peptides, proteins, nucleosides, nucleotides, dimers or oligomers
of nucleosides or nucleotides, enzymes, enzyme cofactors and
derivatives of any of the foregoing, said derivatives having one or
more additional moieties bound thereto; and wherein said at least
one material comprises a second biologically active material, and
the first and second biologically active materials react with one
another when in aqueous solution with one
another..Iaddend..Iadd.
53. A method of forming a glassy state composition which is
storage-stable at 20.degree. C., comprising the steps of: (1)
dissolving to form an aqueous solution of (a) at least one material
to be stored and (b) a carrier substance which is water-soluble or
water-swellable; (2) evaporating water from said solution, thereby
forming said glassy state composition; wherein said glassy state
composition including said carrier substance has the property of
being in a glassy state and being storage stable when at 20.degree.
C.; wherein said at least one material comprises a purified
biologically active material that is unstable in aqueous solution
at 20.degree. C.; wherein said at least one material is selected
from the group consisting of peptides, proteins, nucleosides,
nucleotides, dimers or oligomers of nucleosides or nucleotides,
enzymes, enzyme cofactors and derivatives of any of the foregoing,
said derivatives having one or more additional moieties bound
thereto; wherein said glassy state composition contains no more
than 4 percent by weight of water; and shaping said glassy state
composition into a shape..Iaddend..Iadd.
54. The method of claim 53 wherein said shape is a tablet
form..Iaddend..Iadd.
55. The method of claim 54 wherein said at least one material is
not an enzyme..Iaddend..Iadd.
56. A method of rendering a purified biologically active material
storage-stable at 20.degree. C. and pharmacologically using said
material, which material is unstable in aqueous solution at
20.degree. C., comprising the steps of: (1) dissolving to form an
aqueous solution of (a) a purified biologically active material (i)
which is unstable in aqueous solution at 20.degree. C. and which is
selected from the group consisting of peptides, proteins,
nucleosides, nucleotides, dimers or oligomers of nucleosides or
nucleotides, enzyme cofactors and derivatives of any of the
foregoing, said derivatives having one or more additional moieties
bound thereto and (ii) which is not an enzyme and (b) a carrier
substance that is water-soluble or water-swellable; (2) forming
said solution into a glassy state composition by evaporating liquid
water, wherein said glassy state composition exists when at
20.degree. C.; and (3) administering said purified biologically
active material stored in said glassy state composition; wherein
said carrier substance comprises a member selected from the group
consisting of inulin, polydextrose, stachyose, dextran, sorbose,
polyacrylamide, GPS, and palatinit..Iaddend..Iadd.
57. A method of rendering a purified biologically active material
storage-stable at 20.degree. C. and pharmacologically using said
material, which material is unstable in aqueous solution at
20.degree. C., comprising the steps of: (1) dissolving to form an
aqueous solution of (a) a purified biologically active material (i)
which is unstable in aqueous solution at 20.degree. C. and which is
selected from the group consisting of peptides, proteins,
nucleosides, nucleotides, dimers or oligomers of nucleosides or
nucleotides, enzyme cofactors and derivatives of any of the
foregoing, said derivatives having one or more additional moieties
bound thereto and (ii) which is not an enzyme and (b) a carrier
substance that is water-soluble or water-swellable; (2) forming
said solution into a glassy state composition by evaporating liquid
water, wherein said glassy state composition exists when at
20.degree. C.; and (3) administering said purified biologically
active material stored in said glassy state composition; wherein
said glassy state composition contains no more than 4% by weight
water..Iaddend..Iadd.
58. A process of forming a composition which is storage-stable at
20.degree. C., said composition comprising the steps of: (1)
dissolving to form an aqueous solution (a) a carrier substance
which is water-soluble or water-swellable and (b) at least one
material to be stored; (2) evaporating liquid water from said
solution to convert said solution into a composition in a glassy
state; wherein said composition has the properties that it is
storage-stable and exists in said glassy state when at 20.degree.
C.; wherein said composition contains no more than 4 percent by
weight of water; wherein said at least one material comprises a
purified biologically active material that is unstable in aqueous
solution when at 20.degree. C.; wherein said at least one material
is selected from the group consisting of peptides, proteins,
nucleosides, nucleotides, dimers or oligomers of nucleosides or
nucleotides, enzymes, enzyme cofactors and derivatives of any of
the foregoing, said derivatives having one or more additional
moieties bound thereto; and wherein said step of evaporating
comprises heating the combined carrier substance and purified
biologically active material to a temperature not exceeding
80.degree. C. while maintaining subatmospheric pressure on the
combined carrier substance and purified biologically active
material..Iaddend..Iadd.
59. The process of claim 58 wherein said step of evaporating
comprises heating the combination to at least 30.degree. C. and not
exceeding 80.degree. C..Iaddend..Iadd.
60. A process of forming a composition which is storage-stable at
20.degree. C., said composition comprising the steps of: (1)
dissolving to form an aqueous solution (a) a carrier substance
which is water-soluble or water-swellable and (b) at least one
material to be stored; (2) evaporating liquid water from said
solution to convert said solution into a composition in a glassy
state; wherein said composition has the properties that it is
storage-stable and exists in said glassy state when at 20.degree.
C.; wherein said composition contains no more than 4 percent by
weight of water; wherein said at least one material comprises a
purified biologically active material that is unstable in aqueous
solution when at 20.degree. C.; wherein said at least one material
is selected from the group consisting of peptides, proteins,
nucleosides, nucleotides, dimers or oligomers of nucleosides or
nucleotides, enzymes, enzyme cofactors and derivatives of any of
the foregoing, said derivatives having one or more additional
moieties bound thereto; and wherein said step of evaporating
comprises heating the combined carrier substance and purified
biologically active material to a temperature not exceeding
80.degree. C.; with proviso that when said at least one material
comprises an enzyme, said enzyme comprises an enzyme selected from
dehydrogenase enzymes, restriction enzymes, oxidase enzymes, and
reductase enzymes..Iaddend..Iadd.
61. The process of claim 60 wherein said carrier substance
comprises a water soluble or water swellable synthetic
polymer..Iaddend..Iadd.
62. The process of claim 60 wherein said purified biologically
active material is not an enzyme..Iaddend..Iadd.
63. The process of claim 60 wherein said purified biologically
active material comprises a hormone..Iaddend..Iadd.
64. The process of claim 60 wherein said purified biologically
active material comprises immunoglobulin..Iaddend..Iadd.
65. The process of claim 60 wherein said purified biologically
active material comprises a blood clotting
factor..Iaddend..Iadd.
66. The process of claim 60 wherein said purified biologically
active material comprises a pharmacologically active
protein..Iaddend..Iadd.
67. A glassy state composition which is storage-stable at
20.degree. C., comprising: (1) a carrier substance which is
water-soluble or water-swellable and (2) at least one material to
be stored which is dissolved in said amorphous carrier substance;
wherein said at least one material comprises a purified
biologically active material that is unstable in aqueous solution
at 20.degree. C.; wherein said purified biologically active
material is selected from the group consisting of peptides,
proteins, nucleosides, nucleotides, dimers or oligomers of
nucleosides or nucleotides, enzymes, enzyme cofactors and
derivatives of any of the foregoing, said derivatives having one or
more additional moieties bound thereto; wherein said composition
has the properties that it is storage stable and exists in a glassy
state when at 20.degree. C.; wherein a weight ratio of said
purified biologically active material to said carrier substance is
between about 2:1 and about 1:1; with proviso that when said at
least one material comprises an enzyme, said enzyme comprises an
enzyme selected from dehydrogenase enzymes, restriction enzymes,
oxidase enzymes, and reductase enzymes; wherein said composition
contains no more than four weight percent water..Iaddend..Iadd.
68. A method of rendering a material storage stable at 20.degree.
C. which material is unstable in aqueous solution at room
temperature of 20.degree. C., comprising the steps of: (1)
dissolving to form an aqueous solution (a) said material and (b) a
carrier substance which is water-soluble or water-swellable; (2)
evaporating liquid water from said solution thereby converting said
solution into a glassy state composition; wherein said material
comprises a purified biologically active material that is unstable
in aqueous solution at 20.degree. C.; wherein said biologically
active material is selected from the group consisting of peptides,
proteins, nucleosides, nucleotides, dimers or oligomers of
nucleosides or nucleotides, enzymes, enzyme cofactors and
derivatives of any of the foregoing, said derivatives having one or
more additional moieties bound thereto; wherein said composition
has the property that it is storage stable and exists in said
glassy state when at 20.degree. C.; and wherein a weight ratio of
said purified biologically active material to said carrier
substance is between about 1:2 and about 1:1; with proviso that
when said at least one material comprises an enzyme, said enzyme
comprises an enzyme selected from restriction enzymes, oxidase
enzymes, and reductase enzymes; wherein said composition contains
no more than 4 weight percent water..Iaddend..Iadd.
69. A composition which is storage-stable at 20.degree. C.,
comprising: (1) a carrier substance which is water-soluble or
water-swellable; (2) at least one material to be stored which is
dissolved in said carrier substance; wherein said composition has
the property that it exists in a glassy state when at 20.degree.
C.; wherein said at least one material comprises a purified
biologically active material that is unstable in aqueous solution
at 20.degree. C.; wherein said biologically active material is
selected from the group consisting of peptides, proteins,
nucleosides, nucleotides, dimers or oligomers of nucleosides or
nucleotides, enzyme cofactors and derivatives of any of the
foregoing, said derivatives having one or more additional moieties
bound thereto; wherein said composition contains no more than 4
percent by weight of water; and wherein said biologically active
material is not an enzyme..Iaddend..Iadd.
70. A composition which is storage-stable at 20.degree. C.,
comprising: (1) a carrier substance which is water-soluble or
water-swellable and (2) at least one material to be stored which is
dissolved in said carrier substance; wherein said composition has
the property that it exists in a glassy state when at 20.degree.
C.; wherein said at least one material comprises a purified
biologically active material that is unstable in aqueous solution
at 20.degree. C.; wherein said biologically active material is
selected from the group consisting of peptides, proteins,
nucleosides, nucleotides, dimers or oligomers of nucleosides or
nucleotides, enzyme cofactors and derivatives of any of the
foregoing, said derivatives having one or more additional moieties
bound thereto; wherein said biologically active material is not an
enzyme; and wherein said carrier substance does not comprise
maltotriose..Iaddend..Iadd.
71. A method of forming a composition which is storage-stable at
20.degree. C., comprising the steps of: (1) dissolving to form an
aqueous solution (a) a carrier substance which is water-soluble or
water-swellable and (b) at last one material to be stored; forming
said solution into a glassy state composition by evaporating liquid
water; wherein said composition has the property that it exists in
a glassy state when at 20.degree. C.; wherein said at least one
material comprises a purified biologically active material that is
unstable in aqueous solution at 20.degree. C.; wherein said
biologically active material is selected from the group consisting
of peptides, proteins, nucleosides, nucleotides, dimers or
oligomers of nucleosides or nucleotides, enzyme cofactors and
derivatives of any of the foregoing, said derivatives having one or
more additional moieties bound thereto; wherein said biologically
active material is not an enzyme; and wherein said carrier
substance does not comprise maltotriose..Iaddend..Iadd.
72. A composition which is storage-stable at 20.degree. C.,
comprising: (1) a carrier substance which is water-soluble or
water-swellable and is in a glassy state; (2) at least one material
to be stored which is dissolved in said carrier substance; wherein
said composition exists in a glassy state at 20.degree. C.; wherein
said at least one material comprises a purified biologically active
material that is unstable in aqueous solution at 20.degree. C.;
wherein said purified biologically active material is selected from
the group consisting of peptides, proteins, nucleosides,
nucleotides, dimers or oligomers of nucleosides or nucleotides,
enzymes, enzyme cofactors and derivatives of any of the foregoing,
said derivatives having one or more additional moieties bound
thereto; wherein said composition contains no more than 4 percent
by weight of water; and with proviso that when said at least one
material comprises an enzyme, said enzyme comprises an enzyme
selected from dehydrogenase enzymes, restriction enzymes, oxidase
enzymes, and reductase enzymes..Iaddend..Iadd.
73. A composition which is storage-stable at 20.degree. C.,
comprising: (1) a carrier substance which is water-soluble or
water-swellable and (2) at least one material to be stored which is
dissolved in said carrier substance; wherein said composition has
the property that it exists in a glassy state when at 20.degree.
C.; wherein said at least one material comprises a purified
biologically active material that is unstable in aqueous solution
at 20.degree. C.; wherein said biologically active material is
selected from the group consisting of peptides, proteins,
nucleosides, nucleotides, dimers or oligomers of nucleosides or
nucleotides, enzymes, enzyme cofactors and derivatives of any of
the foregoing, said derivatives having one or more additional
moieties bound thereto; wherein said composition contains no more
than 4 percent by weight of water; with proviso that when said at
least one material comprises an enzyme, said enzyme comprises an
enzyme selected from dehydrogenase enzymes, restriction enzymes,
oxidase enzymes, and reductase enzymes..Iaddend..Iadd.
74. A composition which is storage-stable at 20.degree. C.,
comprising: (1) a carrier substance which is water-soluble or
water-swellable and (2) at least one material to be stored which is
dissolved in said carrier substance; wherein said composition has
the property that it exists in a glassy state when at 20.degree.
C.; wherein said at least one material comprises a purified
biologically active material that is unstable in aqueous solution
at 20.degree. C.; wherein said biologically active material is
selected from the group consisting of peptides, proteins,
nucleosides, nucleotides, dimers or oligomers of nucleosides or
nucleotides, enzymes, enzyme cofactors and derivatives of any of
the foregoing, said derivatives having one or more additional
moieties bound thereto; wherein said carrier substance does not
comprise maltotriose; and with proviso that when said at least one
material comprises an enzyme, said enzyme comprises an enzyme
selected from dehydrogenase enzymes, restriction enzymes, oxidase
enzymes, and reductase enzymes..Iaddend..Iadd.
75. A method of forming a composition which is storage-stable at
20.degree. C., comprising the steps of: (1) dissolving to form an
aqueous solution (a) a carrier substance which is water-soluble or
water-swellable and (b) at least one material to be stored; forming
said solution into a glassy state composition by evaporating liquid
water; wherein said composition has the property that it exists in
a glassy state when at 20.degree. C.; wherein said at least one
material comprises a purified biologically active material that is
unstable in aqueous solution at 20.degree. C.; wherein said
biologically active material is selected from the group consisting
of peptides, proteins, nucleosides, nucleotides, dimers or
oligomers of nucleosides or nucleotide, enzymes, enzyme cofactors
and derivatives of any of the foregoing, said derivatives having
one or more additional moieties bound thereto; wherein said carrier
substance does not comprise maltotriose; and with proviso that when
said at least one material comprises an enzyme, said enzyme
comprises an enzyme selected from dehydrogenase enzymes,
restriction enzymes, oxidase enzymes, and reductase
enzymes..Iaddend.
Description
This invention relates to the stabilisation and storage of
materials. The principal envisaged field of application is
materials employed in the biochemical field and some
pharmaceuticals.
A few biologically active materials (e.g. some proteins) are
sufficiently stable that they can be isolated, purified and then
stored in solution at room temperature. For most materials however
this is not possible and some more elaborate form of
stabilisation/storage procedure must be used.
A "repertoire" of techniques is known. Not all of them are useful
for all materials that give rise to a storage problem. Known
storage/stabilisation techniques which are applied to materials
after isolation into an aqueous suspension or solution are:
(i) Addition of high concentration of chemical "stabilizer" to the
aqueous solution or suspension. Typically 3M ammonium sulphate is
used. However, such additives can alter the measured activity of
enzymes and can give ambiguous or misleading results if the enzyme
is used in a test procedure. (R. H. M. Hatley and F. Franks.
Variation in apparent enzyme activity in two-enzyme assay systems:
Phosphoenolpyruvate carboxylase and malate dehydrogenase.
Biotechnol. Appl. Biochem. 11 367-370 (1989)). In the manufacture
of diagnostic kits based on multi-enzyme assays, such additives
often need to be removed before the final formulation. Such
removal, by dialysis, often reduces the activity of an enzyme.
(ii) Freeze/thaw methods in which the preparation, usually mixed
with an additive (referred to as a cryoprotectant) is frozen and
stored, usually below -50.degree. C., sometimes in liquid nitrogen.
Not all proteins will survive a freeze/thaw cycle.
(iii) Cold storage, with a cryoprotectant additive present in
sufficient concentration (e.g. glycerol) to depress the freezing
point to below the storage temperature and so avoid freezing. For
example in the case of restriction endonucleases, the enzymes need
to be protected against freezing by the addition of high
concentrations of glycerol and maintained at -20.degree. C. Use of
an additive in high concentration may also reduce the specificity
of restriction enzymes and give rise to so-called "star-activity".
(B. Polisky et al. PNAS USA, 72, 3310 (1975)).
(iv) The commonest method for the stabilisation of isolated protein
preparations is freeze-drying, but this process can only be applied
to freeze-stable products. The aqueous isolate of the active
material in a suitable pH buffer and in the presence of a
cryoprotectant is first frozen, typically to -40.degree. to
-50.degree. C.; the ice is then removed by sublimation under vacuum
and at low sub-zero temperatures, following which the residual
moisture which may amount up to 50% of the "dried" preparation is
removed by desorption during which the temperature gradually rises.
The complete freeze-drying cycle may take several days and is
costly in capital and energy. Freeze-drying also suffers from
technical disadvantages because of its irreproducibility. Suppliers
of freeze-dried protein products generally specify storage at
-20.degree. C. rather than ambient temperature. Exposure to ambient
temperatures for periods of days to weeks can result in significant
activity losses.
(v) Undercooling, as described in European Patent 0 136 030 and by
Hatley et al. (Process Biochem. 22 169 (1987)) allows for the
long-term (years) stabilisation of proteins without the need for
additives. However, while this process extended the previous
repertoire of possibilities, the undercooled preparations need to
be shipped at temperatures not exceeding +5.degree. C. and must be
stored, preferably at -20.degree. C. They also have to be recovered
from a water-in-oil dispersion prior to their final use.
It will thus be apparent that a stabilisation/storage process which
enabled storage at ambient temperature would be very desirable,
since it would avoid the need for low temperature storage entailed
by existing processes. Hitherto, however, storage at ambient
temperature has been impossible for many materials.
There would also be advantage in adding to the existing
"repertoire" of processes for stabilisation and storage, because
some of the existing processes are limited in their applications or
entail accepting disadvantages such as a need to mix with a
stabilising agent which is difficult to remove later.
There would furthermore be advantage in providing a more cost
effective process than the current freeze-drying process.
We have found, surprisingly, that materials which are not stable
when isolated and held in solution at room temperature can
nevertheless be successfully incorporated into a glass formed from
a water-soluble or water-swellable substance, and can later be
recovered. While in the glass the material is immobilised and
stable.
In a first aspect this invention provides a storable composition
comprising at least one material to be stored, preferably selected
from the group consisting of proteins, peptides, nucleosides,
nucleotides and enzyme cofactors, dissolved in a water-soluble or
water-swellable substance which is in an amorphous, glassy or (much
less preferably) rubbery state.
As will be explained in more detail below, it is preferred that the
composition displays a glass transition temperature of at least
20.degree. C. preferably at least 30.degree. C.
It may be desirable that the compositions has a water content of
not more than 4% by weight.
The invention may be utilised for stable storage of a single
material, or for a mixture of materials which have little or no
effect on each other.
However, in a development of this invention, a single composition
contains a plurality of materials which form part or all of a
reacting system. These may be fairly simple chemicals.
In a further aspect, this invention provides a method of rendering
a material suitable for storage, comprising dissolving the material
in a water-soluble or water-swellable substance or solution thereof
and forming the resulting mixture into a glass.
This process is capable of being carried out without the use of any
non-aqueous organic solvent, which is advantageous because such
solvent could prove harmful to many substances. Also processing
with and/or removal of organic solvents can be undesirable for
environmental reasons.
A further feature is that the process is energy efficient,
requiring much less energy than freeze drying. Most of the drying
can be done at less than 40.degree. C.
MATERIAL STORED
The material(s) stabilized for storage may potentially be any of a
wide range of materials which are ordinarily liable to undergo a
chemical reaction which is dependent on diffusion of reacting
species.
One category of materials to which the invention is applicable is
proteins and peptides, including derivatives thereof such as
glycoproteins. Such proteins and peptides may be any of: enzymes,
transport proteins, e.g. haemoglobin, immunoglobulins, hormones,
blood clotting factors and pharmacologically active proteins or
peptides.
Another category of materials to which the invention is applicable
comprises nucleosides, nucleotides, dinucleotides, oligonucleotides
(say containing up to four nucleotides) and also enzyme cofactors,
whether or not these are nucleotides. Enzyme substrates in general
are materials to which the invention may be applied.
The material for stabilisation and storage may be isolated from a
natural source, animal, plant, fungal or bacterial, or may be
produced by and isolated from cells grown by fermentation in
artificial culture. Such cells may or may not be genetically
transformed cells.
The material will need to be soluble in aqueous solution, at least
to the extent of forming a dilute solution which can be used for
incorporation into the glass forming substance.
As mentioned above, a development of this invention is to store
more than one component of a reacting system in a glass. This can
be useful for materials which will be required to be used together
in, for example, an assay or a diagnostic kit.
Storing the materials as a single glassy preparation provides them
in a convenient form for eventual use. For instance, if an assay
requires a combination of a substrate, or cofactor and an enzyme,
two or all three could be stored in a glass in the required
concentration ratio and be ready for use in the assay.
If multiple materials are stored, they may be mixed together in an
aqueous solution and then incorporated together into a glass.
Alternatively they may be incorporated individually into separate
glasses which are then mixed together.
When multiple materials are stored as a single composition (which
may be two glasses mixed together) one or more of the materials may
be a protein, peptide, nucleoside, nucleotide or enzyme cofactor.
It is also possible that the materials may be simpler species. For
instance a standard assay procedure may require pyruvate and NADH
to be present together. Both can be stored alone with acceptable
stability. However, when brought together in aqueous solution they
begin to react. If put together in required proportions in the
glassy state they do not react and the glass can be stored.
THE GLASS-FORMING SUBSTANCE
A glass is defined as an undercooled liquid with a very high
viscosity, that is to say at least 10.sup.13 Pa.s, probably
10.sup.14 Pa.s or more.
Normally a glass presents the appearance of a homogeneous,
transparent, brittle solid which can be ground or milled to a
powder. In a glass, diffusive processes take place at extremely low
rates, such as microns per year. Chemical or biochemical changes
including more than one reacting moiety are practically
inhibited.
Above a temperature known in the glass transition temperature
T.sub.g, the viscosity drops rapidly and the glass turns into a
rubber, then into a deformable plastic which at even higher
temperatures turns into a fluid.
The glass forming substance employed in this invention must be
hydrophilic--either water-soluble or water-swellable--so that water
will act as a plasticiser. Many hydrophilic materials, both of a
monomeric and a polymeric nature either exist as or can be
converted into amorphous states which exhibit the glass/rubber
transitions characteristic of amorphous macromolecules. They have
well defined glass transition temperatures T.sub.g which depend on
the molecular weight and a molecular complexity of the glass
forming substance. T.sub.g is depressed by the addition of
diluents. Water is the universal plasticiser for all such
hydrophilic materials. Therefore, the glass/rubber transition
temperature is adjustable by the addition of water or an aqueous
solution.
For this invention it will generally be necessary that the glass
forming substance, when anhydrous or nearly so, displays a glass
transition temperature T.sub.g in a range from 20 to 150.degree.
C., preferably 25 to 70.degree. C. If T.sub.g is towards the higher
end of the range, a lower T.sub.g can be achieved by adding water
which can be removed after the material which is to be stored has
been incorporated into the glass. Mixtures of glass forming
substances may be used if the components are miscible as a solid
solution. If so, material(s) of lower T.sub.g serve as
plasticiser(s) for material(s) of higher T.sub.g.
If T.sub.g of the final composition is sufficiently high, storage
can be at room temperature. However, if T.sub.g of the composition
is close to or below room temperature it may be necessary or
desirable to refrigerate the glassy composition if storage is for a
prolonged period. This is less convenient but still is more
economical than freeze-drying.
If the composition is heated above its T.sub.g during storage, it
will change to its rubbery state. Even in this condition stored
materials are stable for a considerable period of time.
Consequently, it may well do no harm if the temperature of the
stored material is allowed to go above T.sub.g for a limited time,
such as during transportation.
If a composition is maintained above its T.sub.g (and therefore in
a rubbery condition) the storage life will be limited but still
considerable and the benefit of the invention will be obtained to a
reduced extent.
Conversely, if T.sub.g of the composition is well above room
temperature, the composition is better able to withstand storage at
an elevated temperature, e.g. in a hot climate.
As mentioned above, T.sub.g of the formulated composition is
typically 5.degree. below T.sub.g of the anhydrous glass forming
substance.
The glass forming substance should be sufficiently chemically inert
towards the material which is to be incorporated in it. An absolute
absence of chemical reactivity may not be essential, as long as it
is possible to incorporate the material, store the glass, and
recover the material without serious degradation through chemical
reaction.
Many organic substances and mixtures of substances will form a
glassy state on cooling from a melt.
Carbohydrates are an important group of glass forming substances:
thus candy is a glassy form of sugar (glucose or sucrose). The
T.sub.g for glucose, maltose and maltotriose are respectively 31,
43 and 76.degree. C. (L. Slade and H. Levine, Non-equilibrium
behaviour of small carbohydrate-water systems, Pure Appl. Chem. 60
1841 (1988)). Water depresses T.sub.g and for these carbohydrates
the depression of T.sub.g by small amounts of moisture is
approximately 6.degree. C. for each percent of moisture added. We
have determined the T.sub.g value for sucrose at 55.degree. C.
In addition to straightforward carbohydrates, other polyhydroxy
compounds can be used, such as carbohydrate derivates like sorbitol
and chemically modified carbohydrates.
Another important class of glass forming substances are
water-soluble or water-swellable synthetic polymers, such as
polyvinyl pyrrolidone, polyacrylamide or polyethyleneimine. Here
T.sub.g is a function of the molecular weight. Both of these
classes of glass forming substances are suitable for the present
invention.
A group of glass forming substances which may in particular be
employed are sugar copolymers described in U.S. Pat. No. 3,300,474
and sold by Pharmacia under the Registered Trade Mark "Ficoll".
This U.S. patent describes the materials as having molecular weight
5,000 to 1,000,000 and containing sucrose residues linked through
ether bridges to bifunctional groups. Such groups may be alkylene
of 2, 3 or more carbon atoms but not normally more than 10 carbon
atoms. The bifunctional groups serve to connect sugar residues
together. These polymers may for example be made by reaction of the
sugar with a halohydrin or a bis-epoxy compound.
One process of rendering a material storage stable in accordance
with the present invention commences from an aqueous solution of
the material (which will be referred to as the active material),
and a supply of the substance into which it is to be incorporated,
with this substance already in an amorphous state, either glassy or
rubbery.
Then a controlled amount of an aqueous solution containing the
active material is incorporated into the glassy substance, thus
turning it into a rubber: the materials are mixed to homogenise the
glass forming substance with the active material. The rubbery form
has the consistency of a dough and can be rolled or milled into a
thin sheet. This rubber is then subjected to reduced pressure,
possibly accompanied by moderate heat, in order to remove most of
the added moisture. The final product is a glass with a glass
temperature slightly, e.g. approximately 5.degree., below that of
the pure glass forming substance. It can be kept in the form of a
transparent film or ground into a fine powder or compressed into
tablet form. In the glassy state (below T.sub.g) the deterioration
of the active material, by whatever mechanism, is retarded to the
extent that, on practical time-scales, even substances which in
their free states are extremely labile are found to possess long
shelf-lives.
Full biochemical activity is maintained, but locked in, throughout
this period at temperatures below T.sub.g and can be rapidly
released by resolubilization of the glass in an aqueous medium.
The glass forming substance and the amount of solution added to it
are chosen so that the rubbery material
obtained from the addition is at a temperature above its T.sub.g
(or to put it another way, its T.sub.g is below the ambient
temperature) but as moisture is removed the value of T.sub.g
increases to above the ambient temperature.
Preferably the starting substance also has its T.sub.g above
ambient temperature, so that lowering of T.sub.g on addition of
aqueous solution lowers this value from above ambient to below.
However, it would be conceivable to begin with a
moisture-containing substance whose T.sub.g already lies below
ambient, lower it further through addition of aqueous solution of
the material to be incorporated, and finally raise T.sub.g to above
ambient temperature on drying.
The amount of aqueous solution which can and should be added to
form a rubbery dough may well be found by trial and error. It is
likely to be not more than 5% by weight based on the glass forming
substance. The steps of adding solution to form a rubbery dough and
drying this back to a glassy state can be repeated to build up the
concentration of active material in the glass.
If desired, the T.sub.g value of a sample of a glass forming
substance can be determined, and determined again after mixing in
varying amounts of water, so as to be able to plot a graph of
T.sub.g against moisture content.
T.sub.g values can be determined with a differential scanning
calorimeter and can be detected as a point at which a plot of heat
input against temperature passes through an inflection
point--giving a maximum of the first temperature derivative.
Vacuum applied to assist the removal of water from the rubbery
composition need not be particularly hard. Suitably it is less than
90% of normal atmospheric pressure. A pressure which is 80% of
normal atmospheric pressure has been found adequate. A harder
vacuum may be employed, however, if this is found convenient.
Heating of the doughy mixture to remove moisture may be at a
temperature not above 80.degree., and for a protein is preferably
not above 60.degree. C. Heating may not be necessary: evaporation
of moisture under reduced pressure may proceed to a sufficiently
low moisture content even at room temperature of around 20.degree.
C., but of course heat accelerates the evaporation.
Another process for rendering material storage stable in accordance
with the present invention can enable the material to be stored and
recovered at a greater concentration of active material relative to
the carrier substance. In this process a quantity of the carrier
substance, or a solution thereof, is added to a solution of the
active material. When the added carrier substance has dissolved
fully, the solution may be divided into convenient portions, e.g.
0.1 to 1 ml. The samples of solution are placed under reduced
pressure so that water is evaporated from them until the carrier
substance is in a glassy state. Typical conditions are to commence
the evaporation at a temperature not exceeding 40.degree. C.,
preferably in the range from 20 to 30.degree. C. and continue it
for some hours, for instance 24 to 36 hours. As evaporation
continues the glass temperature of the residual material rises.
Evaporation for the period indicated can be sufficient to achieve a
glass transition temperature exceeding 30.degree. C. Once such a
sufficiently high glass transition temperature has been achieved
the temperature may be raised while evaporation continues. For
instance once the glass transition temperature has reached a level
of 30.degree. C. the temperature may be raised to within a range of
40 to 70.degree. C., e.g. 60.degree. C. for a shorter time such as
two hours. For this procedure also, vacuum used to bring about
evaporation of water does not need to be particularly hard. It may
also be found that heating is unnecessary: evaporation without
heating for an extended time may achieve a sufficiently low
moisture content.
In the above, the carrier substance may be added in a dry state,
e.g. a powder, or as a solution.
Recovery (i.e. reactivation) of stored material can be effected by
simply adding water or aqueous solution to a quantity of the glass
with the active material therein. If the carrier substance is
water-soluble the result is a solution of the material and the
carrier substance.
Separation by chromatography to isolate the stored, active material
from the glass forming substance is possible. However, in general
it will be neither desirable nor necessary. Instead the glass
forming substance is chosen so that it will not interfere with the
use (e.g. assay) of the stored, active material.
In the case of a water-swellable glass forming substance, it will
remain out of solution, perhaps as a gel, and the solution of the
material can be separated by centrifugation if required.
The suitability of an intended glass forming substance and
conditions for incorporation of material into it can both be
checked by preparing a glass with the material incorporated, and
then recovering the material without any substantial period of
storage.
Storage stability can, if desired, be tested by storage at a higher
temperature such as 35.degree. C. or even 50.degree. C. which gives
an accelerated test.
EXAMPLES
In the examples which follow, Examples 1 to 4 illustrate the first
process referred to above in which a solution containing the active
material is incorporated into the glassy carrier substance, turning
it temporarily into a rubbery state. Examples 5 onwards illustrate
the second process described above in which the carrier substance
is added to a solution of the active material and the resulting
solution is then evaporated to the glassy state.
In some of the Examples, material is stored at a temperature above
ambient, to provide an accelerated test of storage life.
Examples 1 and 2 describe the storage of lactate dehydrogenase
(LDH) which is assayed using a combination of NADH and pyruvate.
Example 4 shows the storage of the unstable mixture of NADH with
pyruvate. This would provide a suitable material for use in
carrying out LDH assays, but in Example 4 that assay procedure is
used to confirm the activity of the NADH/pyruvate after
storage.
Example 3 describes storage of restriction enzyme, and the activity
of the stored enzyme is confirmed by showing that its effect on DNA
remains unchanged.
EXAMPLE 1
The glass forming substance employed was Ficoll 400 DL (Pharmacia.
Reg. Trade Mark) which is a copolymer of sucrose and
epichlorohydrin. It is water-soluble and has a T.sub.g of
97.degree. C. 4 grams of the Ficoll was weighed (w.sub.s) into a
dry Universal tube. About 50% was placed into a dry mortar and 0.2
ml of a solution containing 1,000 units/ml lactate dehydrogenase
LDH (ex rabbit muscle) in 0.01M phosphate buffer pH 7.0 was added
and mixed well into the Ficoll. A further 0.2 ml of LDH solution
was then incorporated into the mix. A small amount of Ficoll was
added, until a dough was obtained which did not adhere to the
pestle. The dough was rolled out on a tile to give a sheet of
approx 1 mm thickness. It was separated from the tile with a knife
and lightly replaced onto the tile which was then heated in an oven
for 30 minutes at 45-50.degree. C. The sheet was removed from the
oven and ground to a fine free-flowing powder which was stored in a
sealed tube. The unused Ficoll was weighed (w.sub.e). The powder
containing the LDH was stored in the laboratory where temperatures
fluctuated between 20 and 35.degree. C.
The LDH activity of the powder, assuming no loss of LDH activity,
should be given by the relationship: ##EQU1##
where I is the initial concentration of LD in the solution in
units/ml.
The actual LDH activity of the powder was assayed. On the
assumption that the powder contained negligible moisture, the
powder was dissolved in phosphate buffer (0.01M pH 7) to give a
test solution calculated to be a 1 to 1,000 dilution of the
original solution. This would contain 1 unit of LDH per ml if
enzyme activity was entirely preserved. Its actual activity was
determined by the following procedure (Hatley, Franks and Mathias,
Process Biochemistry, December 1987 page 170).
2.7ml of 0.01M phosphate buffer pH 7, 0.1 ml of 2 mg ml.sup.-1
NADH, and 0.1 ml of 10 mM pyruvate were placed into a cuvette of
path length 10 mm. The cuvette was capped and shaken. 0.1 ml of the
test solution was added and the cuvette again capped and shaken.
The absorbance at 340 nm was recorded at 30 second intervals for a
total period of three minutes. The temperature of the solution was
also noted. A period during which the absorbance change was linear
with time was selected and the absorbance change per minute,
.DELTA.A, calculated. The enzyme activity was calculated as
follows: ##EQU2##
where:
.DELTA.A=the absorbance change per minute at 340 nm.
6.25=a correction factor for the molar absorbance of NADH.
TCF=a temperature correction factor which must be applied for
assays performed at temperatures other than 25.degree. C.
C=the concentration of the protein (mg ml.sup.-1). No loss of LDH
activity could be detected after storage for 5 months.
The stability of the product was compared to that of a commercial
LDH preparation in 2.1M ammonium sulphate (Type II, 10,000 units/ml
ex Sigma) which was stored at 25.degree. C. and assayed
periodically by the above method. The activity of this commercial
preparation decreased on average by 1.2% per day over the first 45
days.
EXAMPLE 2
A quantity of crystalline sucrose was gently heated to melting on a
hotplate under a dry, oxygen-free atmosphere. (Dry nitrogen was
used). The sucrose was allowed to cool to give a transparent glass
and was then ground into a fine powder, still under a dry
atmosphere, and stored in a stoppered tube. 0.4 ml of an LDH
solution, containing 4,000 units/ml, in 0.01M phosphate buffer pH
7.0 was added to 4 g of the sucrose glass and mixed using a pestle
and mortar. The resulting paste was rolled out on a tile into a
thin sheet which was then freed from, and lightly replaced on the
tile. It was next heated in an oven for 30 minutes at 40-50.degree.
C. after which it was allowed to cool. It was then ground into a
fine, free-flowing powder, all operations being performed under the
exclusion of moisture. The powder was stored in an air-tight
stoppered tube at 25.degree. C. The LDH activity of the powder,
assuming no loss of activity, should be given by:
where I is the initial LDH activity (units/ml) in the solution used
to prepare the glass.
The preparation was assayed periodically for LDH activity, as
described in Example 1. No loss of activity could be detected after
1 month storage at 25.degree. C.
The glass temperature of the preparation was determined by
differential scanning calorimetry as 32.degree. C.
EXAMPLE 3
To 1 g Ficoll 400 were added 100 .mu.l of a solution of EcoR I
restriction endonuclease in 50% aqueous glycerol and a glass was
prepared as described in Example 1. The final preparation was
stored for 10 days in the laboratory with temperatures fluctuating
between 20 and 30.degree. C.
A quantity of the preparation equivalent to 2 units of enzyme,
based on the assumption that the enzyme was still fully active, was
dissolved in the following buffer: 100 mM Tris-HCl pH 7.5, 10 mM
MgCl.sub.2, 50 mM NaCl, 0.1 mg/ml bovine serum albumin. An assay
for enzyme activity was carried out by the following procedure
(which is taken from LKB Laboratory Manual: LKB 2013 Miniphor
Submarine Electrophoresis Unit 1985, Chapter 6). The solution was
incubated with 1 .mu.g lamda-DNA for 1 hour at 37.degree. C.
Electrophoresis of the incubation mixture was then carried out on
Q.5% agarose gel in Tris/borate buffer in standard manner. The DNA
breakdown bands observed on the gel corresponded exactly with those
of a control run with a fresh enzyme solution.
EXAMPLE 4
A solution containing 100 mg/ml NADH and 33 mg/ml pyruvate was
prepared. 0.4 ml of this solution were incorporated into 4 g of a
sucrose glass and the mixture processed, as described in Example 2.
The mixed glass was stored in 20 mg quantities in spectrophotometer
cuvettes which were closed with sealing film and kept in a
laboratory where the temperature fluctuated between 20 and
35.degree. C. The glass was stored for 14 days.
For purposes of assay, the contents of a cuvette were dissolved in
2.7ml of 0.01M phosphate buffer (pH 7.0) and 0.1 ml of a LDH
solution containing 1 unit/ml was added. The absorbance at 340 nm
was recorded at 30 second intervals for a total period of 3 minutes
and the temperature of the solution was measured. The apparent LDH
enzyme activity was determined from the period during which the
absorbance change was linear with time. The activity was calculated
as in Example 1. A control assay was carried out with fresh
solutions of NADH and pyruvate. The apparent activity obtained
using the dissolved glass closely matched the control value.
EXAMPLE 5
The active material was glutamate dehydrogenase. 532 mg of Ficoll
400 DL as used in Example 1 was added to 20 ml of a glutamate
dehydrogenase solution, containing 13.3 mg/ml protein. The
protein:Ficoll ratio was therefore 1:2. The sample was then divided
into eighty 0.25 ml portions and dried at 37.degree. C. under
reduced pressure (about 80% of atmospheric) for 24 hours. The
sample was then divided into two batches of 40 vials. One batch was
heated under reduced pressure for a further two hours at 60.degree.
C. The batches were then further subdivided and stored under a
range of conditions (see below). Vials were periodically rehydrated
by adding 2.23 ml of 50 mM Tris/HCl buffer at pH 7.5, containing
0.3 mM EDTA to give a solution which, assuming no loss of activity,
would have contained 100 units of enzyme per ml. This was serially
diluted to 1 unit/ml in the same buffer. The actual activity of the
recovered enzyme was determined. The assay procedure for recovered
enzyme made use of the following solutions:
Solutions 1. 50 mM Tris/HCL pH 7.5+0.3 mM EDTA 2. 4.5 mg/ml NADH in
solution 1 3. 4.0125 g NH.sub.4 Cl in 25 ml H.sub.2 O 4. 97 mg
.alpha.-ketoglutarate (disodium salt) in 50 ml solution 1.
To carry out the assay 2.6 ml of solution 4, 0.2 ml of solution 3
and 0.1 ml of solution 2 were mixed in a 3 ml cuvette, 0.1 ml of
the recovered enzymes solution was added. The absorbance at 340 nm
was observed over 5 minutes and the activity of the enzyme
calculated from the change (.DELTA.A) in absorbance during the 5
minute period. Activity was calculated using the following formula:
##EQU3##
The results obtained are set out in the following Table in which
"initial activity" denotes the activity of enzyme which was
recovered after only a minimal period of storage. The activities
are quoted as percentages of the theoretical value of activity
assuming this had been retained fully. A quantity of a commercially
freeze-dried glutamate dehydrogenase (whose activity before freeze
drying was stated by the supplier) was divided into several
portions and stored at 25.degree. C. for varying periods and
assayed in the same way. Its activity is also quoted as percentages
of the theoretical activity. The results for this material ar
included in the Table.
Initial Process Storage Ac- Temper- Temper- tiv- Duration of
Storage (weeks) ature ature ity 1 2 3 4 6 12 37.degree. C. ambient
97% 95% 99% 98% 86% 37.degree. C. 35.degree. C. 97% 78% 82% 87% 84%
37.degree. C. 25.degree. C. 130% 122% 121% 83% 69% 74% 60.degree.
C. ambient 103% 109% 96% 85% 98% 97% 60.degree. C. 35.degree. C.
103% 102% 105% 96% 116% 60.degree. C. 25.degree. C. 121% 114% 125%
84% 81% 89% Freeze- 25.degree. C. 56% 40% 35% 33% 36% dried
As can be seen from these results, experimental error gives rise to
some variation in FIGURES, but these do nevertheless show very
substantial retention of activity over prolonged storage and much
better retention of activity than with freeze-dried material.
EXAMPLE 6
2.50 ml of ascorbate oxidase (21.25 mg protein) solution was
prepared. To this was added 2.50 ml of Tris buffer pH 7.6
containing 21.25 mg Ficoll 400, giving a protein:Ficoll weight
ratio of 1:1. This was then divided into ten 0.5 ml portions and
dried at 37.degree. C. under reduced pressure of about 80% of
atmospheric for 24 hours. The samples were next heated, still under
reduced pressure, for a further two hours at 60.degree. C. Storage
was on a laboratory shelf (temperature fluctuations between 17 and
28.degree. C.). After varying periods of storage, samples were
rehydrated by addition of 2.5 ml of 0.4 mM Na.sub.2 HPO.sub.4
containing 0.5% Bovine serum albumin. It was then serially diluted
in more of the same solution so that its activity would be 0.2
units/ml, if activity had been fully retained, and assayed. The
activity relative to the starting value was determined.
Assay was carried out using a standard assay procedure published by
Boeringer Mannheim. The assay monitors the decrease in absorbance
at 245 nm as the enzyme catalyses the oxidation of a known solution
of ascorbic acid. Enzyme which had been stored for 2 months at
35.degree. C. was found, within the limits of experimental error,
to have the same activity as enzyme which was stored for only a
very short time.
EXAMPLE 7
Lactate dehydrogenase was incorporated into Ficoll 400 using the
procedure of Example 5. The Ficoll:enzyme ratio was 0.23:0.26.
Samples were stored for various periods and then recovered by
adding 0.01M phosphate buffer in a quantity which would give a
theoretical activity of 1 unit/ml, assuming full retention of
activity. The recovered solutions were assayed using the procedure
set out in Example 1. The measured activity of recovered material,
as a percentage of the theoretical activity was:
Before Storage period (days) Drying 1 14 21 28 35 180 100% 91% 81%
91% 112% 97% 98%
EXAMPLE 8
Cytochrome C reductase was incorporated into Ficoll 400 by the
procedure of Example 5. The ratio of enzyme:Ficoll was 1:1. Samples
were subjected to an accelerated test, viz. stored for 14 days at
35.degree. C., and then recovered by adding 4 ml of 0.2M KHCO.sub.3
to give a solution with a theoretical activity of 0.87 unit/ml
assuming full retention of activity. The recovered material was
assayed using a procedure given in "Methods in Enzymology" by
Mahler, Volume II 1955 p. 688. It was found that the recovered
material had an activity of 88% of the theoretical value.
EXAMPLE 9
Glycerol-3-phosphate dehydrogenase was incorporated into Ficoll 400
by the procedure of Examples. The ratio of enzyme:Ficoll was 1:2.
Samples were subjected to an accelerated storage test by storage at
35.degree. C. After 7 days storage the material was recovered by
adding 0.05M Tris/HCl buffer at pH 7.6. This also contained 2 mg/ml
albumin and 0.74 mg/ml EDTA. The recovered material was assayed
using a procedure published by Biozyme Laboratories in which the
enzyme catalyses the reaction:
and the oxidation of NADH is followed spectrophotometrically at 340
nm.
It was found that after 7 days storage at 35.degree. C. the
activity was 96% of the activity of a control sample which was
rehydrated immediately after being incorporated into Ficoll.
EXAMPLE 10
Alpha-glucosidase was incorporated into Ficoll 400 using the
procedure of Example 5. The Ficoll:enzyme ratio was 1:1. As an
accelerated test, samples were stored for various periods at
35.degree. C. and then recovered by adding 4 mls of 0.067M
phosphate buffer at pH 7.0 to give a solution whose theoretical
activity, assuming full retention of activity, was 2 units/ml. The
recovered solutions were assayed by a procedure described by H.
Halvorson, Methods in Enzymology 8 559 (1966). The actual activity
of recovered material relative to the theoretical value was:
Before Storage period (days at 35.degree. C.) Drying 1 4 11 90 100%
100% 103% 95% 70%
EXAMPLE 11
Pyruvate: 5 g of Ficoll 400 was added to 20 ml of 10 mM sodium
pyruvate solution. The solution was then divided into 40 portions,
each containing 0.25 ml portions and processed in the manner
described for Example 5 to give glasses.
NADH: 5 g of Ficoll 400 was added to 20 ml of a 2 mg/ml NADH
solution. This was divided into 40 portions, each containing 0.25
ml, and processed as in Example 5 to give glasses.
At intervals following storage one sample of each reagent was
rehydrated and the solutions mixed. They were assayed by the
standard method described in Example 4. After 3 months storage at
ambient temperature their ability to react in the LDH assay was
100% of the control value obtained at the initiation of
storage.
EXAMPLE 12
NADH and pyruvate were processed as in Example 11. Portions of each
resulting glass powder were mixed together. One such mixture was at
once rehydrated and assayed by the procedure of Example 4. The
reaction mixture consisted of 2.8 mls 0.01M phosphate buffer, 0.1
ml of rehydrated NADH/pyruvate mixture, and 0.1 mls of 1 unit/ml
enzyme solution. The change in absorbance of 340 nm over three
minutes was defined as 100%.
A further mixture was stored for one week and then rehydrated and
assayed in the same way. Within the limits of experimental error,
its activity was the same. Thus there had been no reaction of the
NADH and pyruvate during storage.
EXAMPLE 13
A range of carrier materials were used in a standard procedure in
which the stored active material is lactate dehydrogenase. In each
case, a solution consisting of 0.05 g of carrier dissolved in 100
ml 0.01M phosphate buffer was prepared. 1 ml of 10 mg/ml lactate
dehydrogenase solution was then added to 20 ml of the prepared
solution. The solution thus created was divided into 0.5 ml
aliquots in glass vials. These were dried under reduced pressure of
about 80% atmospheric in a vacuum oven at 36.degree. C. for 24
hours. After drying the vials were sealed and stored at ambient
temperature. The product had a carrier:protein ratio by weight of
1:0.22.
Some samples were rehydrated immediately by addition of phosphate
buffer. Others were stored for various lengths of time and then
rehydrated. The activity of enzyme was determined as in Example 1.
Activity of enzyme is expressed, in each case, as activity relative
to that of enzyme rehydrated in the first week after drying.
Results are set out in the following Table, in which "PVP" denotes
polyvinylpyrollidone, "GPS" denotes
6-O-.alpha.-D-glucopyranosyl-D-sorbitol. "Palatinit" is a product
of Sudzucker Aktiengesellschaft. Mannheim-Ochsenfurt, Germany, and
consisting of an equimolecular mixture of
.alpha.-D-glucopyranosyl-1,6-mannitol and
.alpha.-D-glucopyranosyl-1,6-sorbitol.
Car- Storage period at 25.degree. C. (weeks) rier 1 2 3 4 5 6 8 10
12 16 Malto- 100 114 91 96 68 71 101 94 trose Poly- 100 132 123 103
116 146 103 destrose Inulin 100 99 91 95 114 98 91 Stach- 100 122
137 140 109 106 127 yose Dextran 100 81 71 89 102 91 95 84 Sorbose
100 93 75 76 55 66 65 58 62 Poly- 100 100 80 71 53 62 55 63 acryl-
amide PVP 100 75 76 70 62 GPS 100 124 Palatinit 100 99
* * * * *